Home›Antineoplastic and Immunomodulating Agents›All Antineoplastic and Immunomodulating AgentsBrowse ByAll Antineoplastic and Immunomodulating AgentsReference and ClassificationVerifiedDrugs that treat cancer or that suppress or otherwise modify the immune system, following ATC Group L (Antineoplastic and Immunomodulating Agents). Belongs here: a chemotherapy agent that kills or slows the growth of cancer cells, a hormone antagonist used against a hormone-sensitive cancer, and an immunosuppressant used to prevent transplant rejection or treat autoimmune disease. Does not belong here: an antibiotic used against an infection rather than a cancer, grouped under antiinfective agents for systemic use.FactsAll Antineoplastic and Immunomodulating AgentsSourcesComments (0)Reader Challenges (0)FactsComparisonATC Level 1 CodeWell-attestedSourced to the subject's own accountL - Antineoplastic and immunomodulating agents 1All Antineoplastic and Immunomodulating AgentsFilter Results74 entriesATC ClassAllL: Antineoplastic and Immunomodulating Agents (73)S: Sensory Organs (1)Route of AdministrationAllIntratumoral (2)Intravenous (36)Intravesical (1)Ophthalmic (1)Oral (23)Subcutaneous (7)Topical (2)Approval StatusAllApproved (62)Discontinued (1)Investigational / Clinical Trial (7)Withdrawn (2)Era (First Approved)All1947 (1)1949 (1)1959 (1)1963 (1)1964 (1)1969 (2)1973 (2)1974 (1)1975 (2)1976 (1)1977 (1)1978 (1)1983 (2)1987 (1)1989 (1)1992 (1)1994 (1)1999 (2)2001 (1)2002 (1)2004 (1)2005 (2)2007 (1)2010 (1)2012 (1)2013 (1)2015 (2)2016 (1)2017 (2)2018 (3)2019 (1)2020 (6)2021 (8)2022 (2)2023 (4)2024 (4)2025 (2)2026 (1)WHO Essential MedicineAllComplementary List (15)Treats (Condition)AllArthritis (1)Breast Cancer (2)Cancer (2)COVID-19 (1)Giant cell arteritis (1)Graft-Versus-Host Disease (1)Hidradenitis Suppurativa (1)Mesothelioma (1)Osteopetrosis (1)Psoriasis (1)Rheumatoid Arthritis (1)Severe Acute Respiratory Syndrome (1)Uveitis (1)Wilms Tumor (1)Show ResultsBrowseCompareSelect all 24RemestemcelAntineoplastic and Immunomodulating AgentsRexin GAntineoplastic and Immunomodulating AgentsRipretinibAntineoplastic and Immunomodulating AgentsRucaparibAntineoplastic and Immunomodulating AgentsSacituzumab govitecanAntineoplastic and Immunomodulating AgentsSepsivacAntineoplastic and Immunomodulating AgentsSugemalimabAntineoplastic and Immunomodulating AgentsTabelecleucelAntineoplastic and Immunomodulating AgentsTagraxofuspAntineoplastic and Immunomodulating AgentsTamoxifenAntineoplastic and Immunomodulating AgentsTazemetostatAntineoplastic and Immunomodulating AgentsTemozolomideAntineoplastic and Immunomodulating AgentsTeserpaturevAntineoplastic and Immunomodulating AgentsThiotepaAntineoplastic and Immunomodulating AgentsTislelizumabAntineoplastic and Immunomodulating AgentsTivozanibAntineoplastic and Immunomodulating AgentsTocilizumabAntineoplastic and Immunomodulating AgentsTrametinibAntineoplastic and Immunomodulating AgentsTucatinibAntineoplastic and Immunomodulating AgentsUmbralisibAntineoplastic and Immunomodulating AgentsVincristineAntineoplastic and Immunomodulating AgentsVinorelbineAntineoplastic and Immunomodulating AgentsVorasidenibAntineoplastic and Immunomodulating AgentsVusolimogene oderparepvecAntineoplastic and Immunomodulating Agents← Previous12Sources1. Anatomical Therapeutic Chemical Classification System (Wikipedia)tier 3WikipediaATC Level 1 codes table, group LQuote, ATC Level 1 codes table, group LL - "Antineoplastic and immunomodulating agents"View the SourceComments (0)No comments yet. Be the first to share a thought.Sign in to join the discussion.Reader Challenges (0)No disputes yet. Spotted an error or a better source? Open the first one.Sign in to dispute this or suggest a correction.